Etiology and efficacy of hysteroscopic management in cesarean scar pregnancy: a clinical study
- PMID: 40802397
- PMCID: PMC12341425
- DOI: 10.1590/1806-9282.20241912
Etiology and efficacy of hysteroscopic management in cesarean scar pregnancy: a clinical study
Abstract
Objective: Cesarean scar pregnancy poses significant risks, including uterine scar rupture and increased postpartum hemorrhage. Effective diagnosis and treatment are critical to improving clinical outcomes. This study aimed to analyze the risk factors for cesarean scar pregnancy and evaluate the efficacy and safety of hysteroscopic diagnosis and treatment, providing a theoretical basis for clinical management.
Methods: A total of 122 patients with cesarean scar pregnancy, diagnosed via vaginal ultrasound, were included in the study group and treated with hysteroscopic surgery. A total of 90 pregnant women with prior cesarean sections and normal intrauterine pregnancies were selected as the control group.
Results: Logistic regression identified significant cesarean scar pregnancy risk factors: the number of uterine operations, the number of cesarean sections, and a time interval of ≤5 years since the last cesarean (p<0.05). After hysteroscopic treatment, the mean operation time, intraoperative bleeding, and surgical failure rate were 22.31±6.26 min, 57.23±9.12 mL, and 8.03%, respectively. Surgical failure was associated with gestational age, gestational sac position, gestational sac size, diverticulum angle, and blood β-human chorionic gonadotropin levels (p<0.05). Hysteroscopy demonstrated superior diagnostic accuracy over ultrasound for type II and type III cesarean scar pregnancy cases (p<0.05).
Conclusion: Hysteroscopic surgery improves treatment outcomes in cesarean scar pregnancy patients. Key risk factors for surgical failure include gestational age, gestational sac position, gestational sac size, diverticulum angle, and blood β-human chorionic gonadotropin levels. Early identification and management of these factors can enhance clinical outcomes and reduce complications.
Conflict of interest statement
Similar articles
-
Conservative treatment of cesarean scar pregnancy with the combination of methotrexate and mifepristone: A systematic review.Womens Health (Lond). 2024 Jan-Dec;20:17455057241290424. doi: 10.1177/17455057241290424. Womens Health (Lond). 2024. PMID: 39407415 Free PMC article.
-
Hysteroscopic treatment of Cesarean Scar Pregnancy: A systematic review.Eur J Obstet Gynecol Reprod Biol. 2022 Mar;270:42-49. doi: 10.1016/j.ejogrb.2021.12.038. Epub 2022 Jan 5. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35016136
-
Comparative Analysis of the Efficacy of Four Different Surgical Modalities in the Treatment of Cesarean Scar Pregnancy: A Multicenter Retrospective Study.Adv Ther. 2025 Mar;42(3):1448-1461. doi: 10.1007/s12325-024-03097-0. Epub 2025 Jan 24. Adv Ther. 2025. PMID: 39853658
-
Efficacy and safety of treatment modalities for cesarean scar pregnancy: a systematic review and network meta-analysis.Am J Obstet Gynecol MFM. 2024 Aug;6(8):101328. doi: 10.1016/j.ajogmf.2024.101328. Epub 2024 Mar 12. Am J Obstet Gynecol MFM. 2024. PMID: 38485053
-
Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.Cochrane Database Syst Rev. 2015 Feb 21;(2):CD009461. doi: 10.1002/14651858.CD009461.pub3. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2018 Dec 05;12:CD009461. doi: 10.1002/14651858.CD009461.pub4. PMID: 25701429 Updated.
References
-
- Evidence-Based Complementary and Alternative Medicine Retracted: clinical curative effects and influencing factors of uterine artery chemoembolization combined with uterine curettage treating with cesarean scar pregnancy patients. Evid Based Complement Alternat Med. 2023;2023:9756578–9756578. doi: 10.1155/2023/9756578. - DOI - PMC - PubMed
-
- Li X, Sun W, Chen L, Jin M, Zhang Z, Gao J, et al. Cesarean scar pregnancy combined with arteriovenous malformation successfully treated with transvaginal fertility-sparing surgery: a case report and literature review. Medicine (Baltimore) 2020;99(31):e21432. doi: 10.1097/MD.0000000000021432. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources